Please note that this meeting will take place as an in-person event in Boston, Massachusetts and will not live-stream content for virtual participation. The meeting content will be recorded and made available as an on-demand program after the conference.

All presentations are scheduled to be live, in-person presentations at the date and time specified below unless noted otherwise. Program in progress.

*-Short talk from proffered abstract

Friday, July 24

• Networking Breakfast
• Start-up Shark Tank
• Keynote Lecture
• Plenary Sessions 5-6
  • Plenary Session 5: Degraders in the Era of Precision Oncology
  • Plenary Session 6: Super CARs – Future of CAR-T Cell Therapy
• Closing

Networking Breakfast

7-8 a.m. | Independence Ballroom West

Start-Up Shark Tank

8-9:30 am | Grand Ballroom

Break

9:30-9:45 a.m. | Grand Ballroom Prefunction

Keynote Lecture

9:45-10:45 a.m.

• 9:50 a.m. | Keynote Lecture
  William G. Kaelin, Dana-Farber Cancer Institute, Boston, Massachusetts
• 10:30 a.m. | Q&A

Break

10:45-11 a.m. | Grand Ballroom Prefunction

Plenary Sessions 5-6

11 a.m-1 p.m.

Plenary Session 5: Degraders in the Era of Precision Oncology

Grand Ballroom
Session Chair: Danette Daniels, Foghorn Therapeutics, Cambridge, Massachusetts

• 11:05 a.m. | Challenges and opportunities in PROTAC vs small molecule inhibitors
  Danette L. Daniels
• 11:25 a.m. | Chinatsu Sakata, Astellas, Ibaraki, Japan
• 11:45 a.m. | Induced proximity: Any target, every time
  Ryan Potts, Amgen, Thousand Oaks, California
• 12:05 p.m. | Speaker to be announced
• 12:25 p.m. | Panel Discussion

Plenary Session 6: Super CARs – Future of CAR-T Cell Therapy

Constitution Ballroom A
Session Chair: Saar I. Gill, University of Pennsylvania, Philadelphia, Pennsylvania

• 11:05 a.m. | In vivo CAR-T
  Saar I. Gill
• 11:35 a.m. | Speaker to be announced
• 12:05 p.m. | Armored CAR-T
  Alexandra M. Haugh, Massachusetts General Hospital, Boston, Massachusetts
• 12:35 p.m. | Panel Discussion

Closing Comments and Departure

1 p.m.